Tata Elxsi Ltd
Tata Elxsi Ltd
Information Technology F&OTata Elxsi is amongst the world’s leading providers of design and technology services across industries including Automotive, Media, Communications and Healthcare. Tata Elxsi provides integrated services from research and strategy, to electronics and mechanical design, software development, validation and deployment, and is supported by a network of design studios, global development centers and offices worldwide. [1]
Tata Elxsi trades at a PE of 40.8x with compounded profit declining 11% TTM and 64% of analysts recommending a sell. While the company's debt-free balance sheet and historical ROE of 29% over 3 years are commendable, the sharp deceleration in growth and expensive valuation at 8.43x book value make the risk-reward unfavorable at current levels.
Key Fundamentals
SmallcapComputer Software & ConsultingInformation TechnologyTechnical Indicators
Key Insights
Strengths
3- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.6%
- Company has been maintaining a healthy dividend payout of 63.0%
Weaknesses
1- Stock is trading at 8.25 times its book value
Growth Rate
AI Analysis — Bull vs Bear
Tata Elxsi trades at a PE of 40.8x with compounded profit declining 11% TTM and 64% of analysts recommending a sell. While the company's debt-free balance sheet and historical ROE of 29% over 3 years are commendable, the sharp deceleration in growth and expensive valuation at 8.43x book value make the risk-reward unfavorable at current levels.
- Company is virtually debt-free, providing financial resilience and flexibility for future investments without interest burden
- Strong 3-year ROE track record of 28.6%, indicating efficient capital allocation and high-quality earnings
- Healthy dividend payout ratio of 63% with current dividend yield of 1.82%, offering tangible shareholder returns
- 10-year compounded sales CAGR of 13% demonstrates a long-term structural growth trajectory in the design-led technology services space
- 5-year compounded profit CAGR of 14% shows the company has historically delivered strong earnings growth over a full business cycle
- 10-year stock CAGR of 16% has rewarded long-term investors with meaningful wealth creation
- 5-year ROE average of 32% is significantly above industry average, reflecting a capital-light business model with strong moats
- TTM compounded profit growth has turned negative at -11%, signaling a clear earnings downcycle
- 64% of analysts (9 out of 14) have a sell rating, reflecting broad institutional pessimism on near-term prospects
- Stock has declined 36% over the past 1 year, indicating severe negative momentum and possible further downside
- PE ratio of 40.8x is expensive for a company delivering only 1% TTM revenue growth, implying significant multiple compression risk
- Trading at 8.43x price-to-book value, well above sector averages, leaving limited margin of safety
- 3-year stock CAGR of -19% shows sustained value destruction over a meaningful time horizon
- TTM sales growth has decelerated sharply to just 1% from a 5-year CAGR of 16%, suggesting demand headwinds in key verticals
- Last year ROE dropped to 24% from 3-year average of 29%, indicating declining return efficiency
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Strong Q4 PAT up 27.8% Jun 01
Q4 FY26 profit after tax jumped 27.8% to ₹220.35 crore; revenue from operations rose 9.4% to ₹993.75 crore YoY.
- AI partnership with Sky delivers Jun 24
NEURON platform collaboration with Sky achieved 30% improved operational efficiency, 50% faster change lead times, and 60-70% cost efficiencies in autonomous network transformation.
- AnaTel AI MedTech platform launched May 27
Launched AnaTel with OpenAna to cut SaMD development timelines from 8 weeks to 72 hours and improve productivity by up to 60%, unveiled at DeviceTalks Boston 2026.
- ViTel Material Intelligence for MedTech May 26
Launched ViTel with Viridium AI for medical device manufacturers, addressing sourcing risks, compliance readiness, and material intelligence across the enterprise.
- ₹75/share dividend approved Jun 24
Shareholders approved ₹75 per share dividend at 37th AGM on June 24; payment on or after June 30, 2026.
- 66.2% renewable energy achieved Jun 01
BRSR filing confirms 66.2% renewable energy use, 50% carbon reduction vs 2021 benchmark achieved, zero fines, targeting carbon neutrality by 2030.
- Trading window closed for Q1 Jun 19
Trading window closed from June 24 ahead of Q1 FY26 results; reopens 48 hours after results are declared.
- 37th AGM held June 24 Jun 01
AGM scheduled and held on June 24, 2026 via video conferencing; all resolutions passed including related party transactions with Jaguar Land Rover for FY27.
- Record date set June 10 Jun 01
June 10, 2026 fixed as record date for dividend entitlement; register of members closed June 11-24.
TL;DR: Tata Elxsi is executing well with strong Q4 FY26 financials (PAT +27.8%, revenue +9.4%) and a healthy ₹75 dividend. The company is aggressively building AI-led platforms across MedTech (AnaTel, ViTel) and telecom (NEURON with Sky), positioning itself in high-growth regulated domains. No visible headwinds emerged in the recent news cycle. The upcoming Q1 FY26 results will be key to confirming whether the growth momentum in media/communications (32.7% of revenue) and transportation segments is sustaining.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 838 | 850 | 882 | 914 | 906 | 926 | 955 | 939 | 908 | 892 | 918 | 953 | 994 |
| Expenses | 588 | 599 | 618 | 644 | 645 | 674 | 689 | 693 | 701 | 705 | 725 | 731 | 749 |
| Operating Profit | 250 | 251 | 264 | 270 | 261 | 252 | 266 | 247 | 208 | 187 | 193 | 222 | 245 |
| OPM % | 30% | 30% | 30% | 30% | 29% | 27% | 28% | 26% | 23% | 21% | 21% | 23% | 25% |
| Other Income | 26 | 22 | 31 | 35 | 34 | 32 | 64 | 40 | 43 | 38 | 49 | -50 | 51 |
| Interest | 4 | 4 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 |
| Depreciation | 21 | 21 | 25 | 25 | 28 | 27 | 27 | 26 | 25 | 24 | 23 | 23 | 23 |
| PBT | 250 | 248 | 264 | 274 | 262 | 252 | 299 | 256 | 221 | 196 | 215 | 146 | 268 |
| Tax % | 19% | 24% | 24% | 25% | 25% | 27% | 23% | 22% | 22% | 26% | 28% | 26% | 18% |
| Net Profit | 202 | 189 | 200 | 206 | 197 | 184 | 229 | 199 | 172 | 144 | 155 | 109 | 220 |
| EPS in Rs | 32.36 | 30.32 | 32.12 | 33.15 | 31.62 | 29.56 | 36.84 | 31.95 | 27.68 | 23.18 | 24.85 | 17.48 | 35.37 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 849 | 1,075 | 1,237 | 1,386 | 1,597 | 1,610 | 1,826 | 2,471 | 3,145 | 3,552 | 3,729 | 3,757 |
| Expenses | 672 | 827 | 964 | 1,039 | 1,181 | 1,266 | 1,303 | 1,704 | 2,182 | 2,505 | 2,755 | 2,909 |
| Operating Profit | 177 | 248 | 274 | 347 | 416 | 344 | 524 | 767 | 962 | 1,047 | 974 | 848 |
| OPM % | 21% | 23% | 22% | 25% | 26% | 21% | 29% | 31% | 31% | 29% | 26% | 23% |
| Other Income | 4 | 12 | 18 | 43 | 43 | 58 | 40 | 45 | 74 | 122 | 179 | 88 |
| Interest | 1 | 1 | 1 | 1 | 1 | 7 | 7 | 10 | 17 | 21 | 20 | 18 |
| Depreciation | 25 | 23 | 27 | 25 | 25 | 43 | 44 | 55 | 81 | 99 | 105 | 94 |
| PBT | 156 | 236 | 264 | 364 | 433 | 352 | 512 | 745 | 938 | 1,049 | 1,028 | 825 |
| Tax % | 34% | 34% | 34% | 34% | 33% | 27% | 28% | 26% | 19% | 24% | 24% | 24% |
| Net Profit | 103 | 155 | 175 | 240 | 290 | 256 | 368 | 550 | 755 | 792 | 785 | 628 |
| EPS in Rs | 16.52 | 24.85 | 28.05 | 38.54 | 46.56 | 41.12 | 59.11 | 88.26 | 121 | 127 | 126 | 101 |
| Div. Payout % | 33% | 28% | 29% | 29% | 29% | 40% | 81% | 48% | 50% | 55% | 60% | 74% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31 | 31 | 31 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 |
| Reserves | 252 | 355 | 527 | 676 | 880 | 1,028 | 1,290 | 1,539 | 2,023 | 2,443 | 2,798 | 2,979 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 58 | 73 | 138 | 185 | 225 | 192 | 162 |
| Other Liabilities | 182 | 214 | 158 | 207 | 201 | 241 | 291 | 430 | 493 | 457 | 533 | 759 |
| Total Liabilities | 465 | 600 | 715 | 945 | 1,143 | 1,389 | 1,717 | 2,169 | 2,764 | 3,187 | 3,586 | 3,963 |
| Fixed Assets | 98 | 107 | 108 | 94 | 101 | 147 | 170 | 272 | 334 | 396 | 318 | 259 |
| CWIP | 3 | 2 | 1 | 2 | 0 | 1 | 7 | 22 | 7 | 2 | 2 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 364 | 491 | 607 | 848 | 1,042 | 1,241 | 1,540 | 1,876 | 2,423 | 2,789 | 3,266 | 3,703 |
| Total Assets | 465 | 600 | 715 | 945 | 1,143 | 1,389 | 1,717 | 2,169 | 2,764 | 3,187 | 3,586 | 3,963 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 143 | 121 | 144 | 197 | 215 | 256 | 437 | 483 | 487 | 701 | 812 | 664 |
| Investing | -29 | -31 | 28 | -245 | -162 | 43 | -439 | -106 | -201 | -274 | -311 | -70 |
| Financing | -32 | -41 | -52 | -60 | -83 | -124 | -126 | -326 | -303 | -428 | -499 | -535 |
| Net Cash Flow | 83 | 49 | 120 | -108 | -30 | 175 | -128 | 51 | -17 | -1 | 2 | 59 |
| Free Cash Flow | 110 | 84 | 118 | 185 | 184 | 233 | 399 | 412 | 423 | 618 | 796 | 654 |
| CFO/OP | 103 | 79 | 88 | 90 | 86 | 100 | 107 | 90 | 70 | 92 | 106 | 105 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 73 | 72 | 81 | 81 | 89 | 98 | 99 | 113 | 100 | 95 | 105 |
| Inventory Days | — | — | — | 0 | 6 | 8 | — | 2 | 1 | 2 | — | — |
| Days Payable | — | — | — | — | 205 | 212 | — | 244 | 202 | 162 | — | — |
| Cash Conversion Cycle | 66 | 73 | 72 | 81 | -117 | -116 | 98 | -143 | -88 | -60 | 95 | 105 |
| Working Capital Days | 10 | 26 | 54 | 59 | 69 | 72 | 53 | 47 | 75 | 72 | 65 | 53 |
| ROCE % | 60% | 71% | 56% | 57% | 51% | 35% | 40% | 48% | 48% | 43% | 36% | 30% |
Documents
Frequently Asked Questions about Tata Elxsi Ltd
What does Tata Elxsi Ltd do?
Where is Tata Elxsi Ltd (TATAELXSI) listed?
Which sector does Tata Elxsi Ltd belong to?
What is the market capitalisation of Tata Elxsi Ltd?
What is the PE ratio of Tata Elxsi Ltd?
What is the 52-week high and low of Tata Elxsi Ltd?
Does Tata Elxsi Ltd pay dividends?
What is the Return on Equity (ROE) of Tata Elxsi Ltd?
How can I research Tata Elxsi Ltd on Tapetide?
Company Information
Tata Elxsi is amongst the world’s leading providers of design and technology services across industries including Automotive, Media, Communications and Healthcare. Tata Elxsi provides integrated services from research and strategy, to electronics and mechanical design, software development, validation and deployment, and is supported by a network of design studios, global development centers and offices worldwide. [1]